Key result
Cardiac MRI emerges as the primary diagnostic tool in pediatric viral myocarditis, while targeted therapies lack robust evidence.
This review highlights the diagnostic utility of CMRI and underscores the urgent need for pediatric-specific randomized trials for immunomodulatory and immunosuppressive therapies in viral myocarditis.
Answers are grounded in this paper and cite their sources.
Cardiac MRI may be prioritized for pediatric viral myocarditis diagnosis; leaves open immunosuppression efficacy pending pediatric RCTs.
In viral myocarditis, viral invasion of the heart can lead to direct and indirect inflammatory destruction of the myocardium. Various etiological agents, ranging from enterovirus to adenovirus can cause myocarditis. The clinical presentation is heterogeneous and can end up in a dilated cardiomyopathy phenotype, leading to major mortality, morbidity, and years lost in children. Early recognition and diagnosis with echocardiogram, endomyocardial biopsy, and cardiac MRI is important. Treatment options include with immunosuppression and immunomodulation in the early phases and may require cardiac transplantation in end-stage heart failure.
No takes yet. Share an insight, caveat, or question.
Mahimarangaiah et al. (2021) conducted a review in Viral myocarditis. Diagnostic and therapeutic strategies for viral myocarditis was evaluated. Viral myocarditis in children is a heterogeneous condition where cardiac MRI has rapidly emerged as the diagnostic modality of choice, while therapies like immunosuppression lack strong pediatric evidence.
Synapse has enriched 10 related papers. Consider them for comparative context: